Article
Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy.
Cancer letters - 1 Oct 2014
Pavese Janet M, Bergan Raymond C
Abstract excerpt
With prostate cancer (PCa), circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) portend a poor clinical prognosis. Their unknown biology precludes rational therapeutic design. We demonstrate that CTC and DTC cell lines, established from mice bearing human PCa orthotopic implants, exhibit increased cellular invasion in vitro, increased metastasis in mice, and express increased epithelial to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
